Nicole Herzkovich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nicole Herzkovich has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Siniawski
Consejo de Epidemiología y Prevención Cardiovascular, Sociedad Argentina de Cardiología. Servicio de Cardiología, Hospital Italiano de Buenos Aires
1 shared publication - Eliana Kerschner
Servicio de Cardiología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
1 shared publication - Emiliano Rossi
Servicio de Cardiología, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
1 shared publication - Juan Patricio Nogueira
Endocrinology, Nutrition and Metabolism Research Center, Faculty of Health Sciences, Universidad Nacional de Formosa, Formosa, Argentina
1 shared publication Leandro Barbagelata
Servicio de Cardiología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
1 shared publication- María V. Ami
Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
1 shared publication
Latest Publications
- Open Access
- 7 February 2023
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 67 (3) , 408-415
Screening program for familial hyperchylomicronemia syndrome detection: Experience of a university health system
Objective: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive metabolic disorder caused by mutations related to chylomicron metabolism. The objective of this study is to show the development and results of a screening program for FCS in Argentina. Materials and methods: A cross-sectional study was performed. All patients > 18 years with a triglyceride level ≥ 1,000 mg/dL in the period from January 1, 2017 to December 31, 2021 were included. The program was developed in three stages: [...] ABSTRACT Objective: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive metabolic disorder caused by mutations related to chylomicron metabolism. The objective of this study is to show the development and results of a screening program for FCS in Argentina. Materials and methods: A cross-sectional study was performed. All patients > 18 years with a triglyceride level ≥ 1,000 mg/dL in the period from January 1, 2017 to December 31, 2021 were included. The program was developed in three stages:
- 7 February 2023
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 67 (3) , 408-415
Open AccessScreening program for familial hyperchylomicronemia syndrome detection: Experience of a university health system
Objective: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive metabolic disorder caused by mutations related to chylomicron metabolism. The objective of this study is to show the development and results of a screening program for FCS in Argentina. Materials and methods: A cross-sectional study was performed. All patients > 18 years with a triglyceride level ≥ 1,000 mg/dL in the period from January 1, 2017 to December 31, 2021 were included. The program was developed in three stages: [...] ABSTRACT Objective: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive metabolic disorder caused by mutations related to chylomicron metabolism. The objective of this study is to show the development and results of a screening program for FCS in Argentina. Materials and methods: A cross-sectional study was performed. All patients > 18 years with a triglyceride level ≥ 1,000 mg/dL in the period from January 1, 2017 to December 31, 2021 were included. The program was developed in three stages: